tiprankstipranks
Trending News
More News >
Agentix Corp. (AGTX)
OTHER OTC:AGTX
US Market

Agentix (AGTX) Price & Analysis

Compare
11 Followers

AGTX Stock Chart & Stats

$0.04
$0.03(16.63%)
At close: 4:00 PM EST
$0.04
$0.03(16.63%)

AGTX FAQ

What was Agentix Corp.’s price range in the past 12 months?
Agentix Corp. lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
    What is Agentix Corp.’s market cap?
    Agentix Corp.’s market cap is $1.68M.
      When is Agentix Corp.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Agentix Corp.’s earnings last quarter?
      Currently, no data Available
      Is Agentix Corp. overvalued?
      According to Wall Street analysts Agentix Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Agentix Corp. pay dividends?
        Agentix Corp. does not currently pay dividends.
        What is Agentix Corp.’s EPS estimate?
        Agentix Corp.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Agentix Corp. have?
        Agentix Corp. has 40,066,950 shares outstanding.
          What happened to Agentix Corp.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Agentix Corp.?
          Currently, no hedge funds are holding shares in AGTX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Agentix Corp.

            Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
            Similar Stocks
            Company
            Price & Change
            Follow
            Scinai Immunotherapeutics
            GT Biopharma
            Aditxt
            CERo Therapeutics Holdings
            Psyence Biomedical
            Popular Stocks